Parameter | Non-diabetic (control) | ET2D | LT2D | ||||||
---|---|---|---|---|---|---|---|---|---|
Control | CSE-control | NIA/STZ | CSE- NIA/STZ | Met-NIA/STZ | STZ | CSE-STZ | Met-STZ | Asp-STZ | |
Weight (g ± SD) | |||||||||
Time zero | 185.1 ± 4.3 | 192.8 ± 2.5 | 241.2 ± 22.1 | 236.8 ± 30.0 | 264.3 ± 23.5 | 248.1 ± 16.7aa | 240.4 ± 35.1 | 260.7 ± 10.4 | 256.8 ± 17.2 |
Diabetes induction, start of treatment (day 10) | 192.1 ± 9.2 | 194.6 ± 6.6 | 226.8 ± 23.1 | 248.6 ± 21.1 | 252.5 ± 26.4 | 239.1 ± 8.4aaa | 232.0 ± 32.5 | 226.3 ± 16.6*** | 238.6 ± 26.3 |
End of 21 day treatment time (day 31) | 232.1 ± 20.8††,§§ | 217.8 ± 12.6††,§ | 229.4 ± 15.8 | 258.3 ± 14.3§ | 258.5 ± 19.1 | 222.8 ± 16.3§ | 215.4 ± 32.6§ | 231.3 ± 13.3††† | 234.8 ± 18.8†† |
FBS (mg/dl ± SD) | |||||||||
Time zero | 119.5 ± 5.7 | 111.8 ± 7.5 | 95.2 ± 6.3aa | 99.0 ± 5.8aa | 98.8 ± 9.2a | 99.3 ± 12.3 | 108.2 ± 8.4 | 97.4 ± 5.1aa | 98.5 ± 3.9aa |
Diabetes induction, start of treatment (day 10) | 111.3 ± 7.3** | 107.0 ± 11.6 | 202.2 ± 8.3aaa,*** | 153.0 ± 12.61bb,*** | 222.4 ± 9.7aaa,*** | 401.5 ± 32.6aaa,*** | 346.8 ± 19.5aaa*** | 341.0 ± 16.5aaa*** | 307.8 ± 7.4aaa,c,*** |
End of 21 day treatment time (day 31) | 107.8 ± 11.1† | 103.5 ± 6.1 | 305.4 ± 88.4†† | 82.3 ± 10.2b,††,§§§ | 307.4 ± 156.7† | 398.6 ± 25.5bbb,††† | 365.4 ± 44.5††† | 371.0 ± 67.9††† | 454.8 ± 72.1†††,§§ |